AbbVie will test lutikizumab together with ABBV-295, the amylin-based obesity drug it licensed from Danish biotech Gubra, ...
China has more house dust mite allergy sufferers than any other country, but fewer than 1 million of an estimated 100 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results